Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

The role of carrier geometry in overcoming biological barriers to drug delivery

  • Carolyn Jordan
  • , Vladimir V. Shuvaev
  • , Mark Bailey
  • , Vladimir R. Muzykantov
  • , Thomas D. Dziubla

Producción científica: Review articlerevisión exhaustiva

18 Citas (Scopus)

Resumen

For a variety of diseases, effective therapy is severely limited or rendered impossible due to an inability to deliver medications to the intended sites of action. Multiple barriers exist through the body, which have evolved over time to limit the migration of foreign compounds from entering the tissues. Turning toward biology as inspiration, it has been the general goal of drug delivery to create carrier strategies that mimic, in part, features of bacteria/ viruses that allow them overcome these barriers. By packaging drugs into nano and micron scale vehicles, it should be possible to completely change the biodistribution and residence times of pharmaceutically active compounds. Recently, due to advances in formulation technologies, it has become possible to control not just the material selection, surface chemistry, and/or size, but also the overall geometry and plasticity of the drug carriers. These approaches aid in the formulation of nonspherical particles such as, discs, rods, and even unique structures such as cubes and nanodiamonds. The adjustment of size and shape can be used for the aid or prevention in cellular uptake and also to overcome the vascular and mucosal barrier. In this review, we present a summary of some approaches used to control carrier shape and the impact these geometries have upon drug transport across biological barriers.

Idioma originalEnglish
Páginas (desde-hasta)1259-1273
Número de páginas15
PublicaciónCurrent Pharmaceutical Design
Volumen22
N.º9
DOI
EstadoPublished - mar 1 2016

Nota bibliográfica

Publisher Copyright:
© 2016 Bentham Science Publishers.

Financiación

This work was supported by grants from the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR00011 (Dziubla, Jordan, Bailey), and National Heart, Lung and Blood Institute, National Institutes of Health through grants R01 HL087036(Muzykantov) and R01 HL125462 (Muzykantov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)UL1TR00011
National Heart, Lung, and Blood Institute (NHLBI)R01 HL125462, R01HL087036
National Center for Advancing Translational Sciences (NCATS)

    ASJC Scopus subject areas

    • Pharmacology
    • Drug Discovery

    Huella

    Profundice en los temas de investigación de 'The role of carrier geometry in overcoming biological barriers to drug delivery'. En conjunto forman una huella única.

    Citar esto